European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

4 EU fundings (€501,120): Synaptic Dysfunction in Alzheimer Disease … BdlYear 2015 EU Research and Innovation programme "Horizon"

Text

Crossroads Bank for Enterprises (KBO) 0403.834.160

01/07/2015 EU funding (€1,130,000): Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890
01/01/2015 EU funding (€3,108,939): Improving Design, Evaluation and Analysis of early drug development Studies
11/08/2015 EU funding (€3,846,736): Synaptic Dysfunction in Alzheimer Disease
26/06/2015 EU funding (€3,910,140): Exascale Compound Activity Prediction Engine

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Janssen Pharmaceutica N.V., Beerse, Belgium.

Creative Commons License The visualizations for "4 EU fundings (€501,120): Synaptic Dysfunction in Alzheimer Disease …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.